MARIO SZNOL, MD
Osteopathic Medicine in New Haven, CT

License number

Connecticut 0358548

Personal information

See more information about MARIO SZNOL at radaris.com

Name

Address

Phone

Mario Sznol

360 State St APT 1704, New Haven, CT 06510

Mario Sznol

186 Rimmon Rd, Woodbridge, CT 06525

Mario Sznol

240 Fountain St, New Haven, CT 06515

Organization information

See more information about MARIO SZNOL at bizstanding.com

Mario Sznol MD

800 Howard Ave, New Haven, CT 06519

Industry:

Oncology, Internist

Phone:

(203) 785-4191 (Phone)

Mario . Sznol

Yale Cancer Center - Mario Sznol MD

800 Howard Ave, New Haven, CT 06519

Categories:

Oncology Physicians & Surgeons, Physicians & Surgeons

Phone:

(203) 785-4199 (Phone)

Professional information

See more information about MARIO SZNOL at trustoria.com

Dr. Mario Sznol, New Haven CT - MD (Doctor of Medicine)

Specialties:

Oncology, Medical Oncology

Address:

Smilow Cancer Hospital
35 Park St, New Haven 06519
(203) 688-4242 (Phone)
Milo Multispecialty Care Center
35 Park St, New Haven 06519
(203) 785-4191 (Phone)

Certifications:

Internal Medicine, 1985, Medical Oncology, 1987

Awards:

Healthgrades Honor Roll

Languages:

English, Spanish

Hospitals:

Smilow Cancer Hospital
35 Park St, New Haven 06519
Milo Multispecialty Care Center
35 Park St, New Haven 06519
Yale - New Haven Hospital
20 York St, New Haven 06510

Education:

Medical School
Baylor University
Graduated: 1982
Baylor Coll
Mount Sinai Hospital

Mario Sznol, New Haven CT

Specialties:

Internal Medicine, Medical Oncology, Hematology & Oncology, Psychiatry, Geriatric Psychiatry

Work:

Smilow Cancer Center
20 York St, New Haven, CT 06510 Yale University
800 Howard Ave, New Haven, CT 06519 Yale University
333 Cedar St, New Haven, CT 06510

Education:

Baylor College of Medicine (1982)

Antiviral Agents And Methods Of Treating Viral Infections

US Patent:

2005026, Nov 24, 2005

Filed:

Mar 30, 2005

Appl. No.:

11/093648

Inventors:

Ivan King - North Haven CT, US
Terrance Doyle - Killingworth CT, US
Mario Sznol - Woodbridge CT, US
Alan Sartorelli - Woodbridge CT, US
Yung-chi Cheng - Woodbridge CT, US

Assignee:

Vion Pharmaceuticals, Inc. - New Haven CT
Yale University - New Haven CT

International Classification:

A61K031/675, A61K031/44

US Classification:

514089000, 514352000

Abstract:

The present invention relates to methods of treating viral or fungal infections using 3-aminopyridine-2-carboxyaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone (3-AMP) and its prodrug forms and to pharmaceutical compositions comprising these compounds.

Antiviral Agents And Methods Of Treating Viral Infections

US Patent:

2002018, Dec 12, 2002

Filed:

Apr 18, 2002

Appl. No.:

10/126050

Inventors:

Ivan King - North Haven CT, US
Terrance Doyle - Killingworth CT, US
Mario Sznol - Woodbridge CT, US
Alan Sartorelli - Woodbridge CT, US
Yung-Chi Cheng - Woodbridge CT, US

International Classification:

A61K031/44

US Classification:

514/353000

Abstract:

Combination Therapy Comprising Cloretazine

US Patent:

7605137, Oct 20, 2009

Filed:

Mar 25, 2005

Appl. No.:

10/593217

Inventors:

Ivan King - North Haven CT, US
Mario Sznol - Woodbridge CT, US
Michael Belcourt - Wallingford CT, US

Assignee:

Vion Pharmaceuticals, Inc. - New Haven CT

International Classification:

A61K 31/175, A61K 31/52, A61K 31/505

US Classification:

514 43, 514 45, 514 46, 514 50, 514 86, 514274, 564 35

Abstract:

This invention provides a method for treating tumor in a subject comprising administering to the subject an effective amount of: (1) VNP40101M, or its equivalent; and (2) a nucleoside, or a nucleoside analog. This invention also provides a method for inhibiting tumor cell growth comprising contacting the tumor cell with effective amounts of: (1) VNP40101M, or its equivalent; and (2) a nucleoside, or a nucleoside analog. The present invention relates to the treatment of cancer, comprising administering to a subject in need thereof an effective amount of VNP40101M in combination with a nucleoside.